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Introduction: There is renewed interest in extracellular vesicles over the past decade or 2 after initially being
thought of as simple cellular garbage cans to rid cells of unwanted components. Although there has been
intense research into the role of extracellular vesicles in the fields of tumour and stem cell biology, the possible
role of extracellular vesicles in nerve regeneration is just in its infancy.
Background: When a peripheral nerve is damaged, the communication between spinal cord motor neurons
and their target muscles is disrupted and the result can be the loss of coordinated muscle movement. Despite
state-of-the-art surgical procedures only approximately 10% of adults will recover full function after
peripheral nerve repair. To improve upon such results will require a better understanding of the basic
mechanisms that influence axon outgrowth and the interplay between the parent motor neuron and the distal
end organ of muscle. It has previously been shown that extracellular vesicles are immunologically tolerated,
display targeting ligands on their surface, and can be delivered in vivo to selected cell populations. All of these
characteristics suggest that extracellular vesicles could play a significant role in nerve regeneration.
Methods: We have carried out studies using 2 very well characterized cell lines, the C2C12 muscle cell line and
the motor neuron cell line NSC-34 to ask the question: Do extracellular vesicles from muscle influence cell
survival and/or neurite outgrowth of motor neurons?
Conclusion: Our results show striking effects of extracellular vesicles derived from the muscle cell line on the
motor neuron cell line in terms of neurite outgrowth and survival.
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C
lassical neuroscience experiments carried out al-
most 40 years ago demonstrated that if a foreign
nerve was sutured to a muscle, axons from the
foreign nerve would growover the surface of the normally
innervated muscle but they would not enter the muscle
and form neuromuscular junctions. However, shortly
after denervation of the original nerve that innervated
the muscle, motor axons from the foreign nerve would
now enter the muscle and form functional neuromuscular
contacts (1,2). This suggests that the acutely denervated
muscle was secreting signals, operating over some dis-
tance, that successfully directed the foreign nerve
fibres to neuromuscular junctions. More recently it has
been shown that several neurotrophic factors are indeed
increased in muscle due to denervation (e.g. HGF,
FGFs, BDNF) (39), and that the increased endocyto-
tic/exocytotic activity that has been observed occurs
predominantly at the endplate region of the muscle
(10). These observations have led to the suggestion that
the high exocytotic activity of denervated muscle is due to
the increased secretion of various factors by the muscle
in an attempt to stimulate reinnervation by regenerat-
ing axons of motor neurons (1115). There is also a vast
amount of data that soluble extracts of conditioned
media from muscle can act as a trophic factor for motor
neurons (16). Given such well-known influences of
muscle on motor neuron development and regeneration
(e.g. see Ref. (17) for a classic review), we have begun to

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the soluble fraction, extracellular vesicles derived from
muscle cells may stimulate survival and neurite out-
growth from motor neurons.
The term extracellular vesicles is quite inclusive, gen-
erally referring to exosomes (B100 nm) and microvesi-
cles, ectosomes, or shed vesicles ( 100 nm) (18). We have
adopted this general nomenclature for the present work
while being well aware that future work in the field
may lead to more specific categories based on selected
characteristics of such vesicles. Nanometer-sized secreted
vesicles were originally described more than 30 years
ago and were thought to act as cellular ‘‘garbage cans’’
containing unwanted molecular components; they re-
mained little studied for at least 10 years. Over the past
few years there has been an explosive interest in these
small vesicles because of the discovery that they become a
protected environment for various forms of RNA as well
as proteins and thus function as a novel mechanism for
long-distance intercellular signalling. This unique func-
tion was confirmed when it was shown that secreted
extracellular vesicles containing mRNA from one cell
type can be translated into protein in recipient target
cells (19). A current PubMed search now reveals several
thousands of articles about extracellular vesicles, with
most of them occurring in the last 45 years. Extra-
cellular vesicles are secreted by just about every cell type
that has been examined, including tumour cells, reticulo-
cytes, epithelial cells, neurons, and most pertinent for our
work, muscle cells and Schwann cells (2025), and extra-
cellular vesicles are found in most biological fluids includ-
ing blood, urine, and cerebrospinal fluid (26). However,
because there are no procedures for harvesting extra-
cellular vesicles from intact tissue (as opposed to biolog-
ical fluids), investigators must rely on in vitro approaches
to both produce and harvest exosomes from specific
cellular populations. We have taken advantage of 2 very
well characterized cell lines, the C2C12 muscle cell line
and the motor neuron cell line NSC-34 to ask the ques-
tion: do extracellular vesicles from muscle influence cell
survival and/or neurite outgrowth from motor neurons?
Materials and methods
Cell culture
All cells were grown in a humidified atmosphere of 5%
CO2 and 95% air at 378C.
C2C12
The C2C12 skeletal muscle cell line was obtained from
the American Type Culture Collection (#CRL-1772).
Growth media consisted of Dulbecco’s modified Eagle’s
medium (DMEM) (Cellgro, Manassas, VA) supplemen-
ted with 10% foetal bovine serum (FBS; Atlanta Bio-
logicals, Lawrenceville, GA), 4 mM L-glutamine (Gibco,
Life Technologies, Grand Island, NY), 1 mM sodium
pyruvate (Gibco), 2.5 mg/ml amphotericin B (Fisher Sci-
entific, Fair Lawn, NJ) and 100 U/ml penicillin/100 mg/ml
streptomycin (Gibco). Cells were sub-cultured every 34
days prior to reaching confluence. To differentiate the
cells into myotubes, cultures were placed into differentia-
tion media; AIM-V serum-free medium (Gibco). Myosin
expression was used as a marker for cell differentiation
as indicated by immunofluorescence and Western blot
using standard methods. Primary antibodies were against
myosin (Millipore, clone A4.1025) and beta-actin (Santa
Cruz C4 sc-47778); secondary antibody was an HRP-
conjugate (Jackson, 115-035-003). Conditioned media
was harvested between 48 and 96 hours after differentia-
tion, spun at 3,000 g for 10 minutes, and stored frozen
at 808C until use.
Extracellular vesicle purification and labelling
Extracellular vesicles were isolated with slight modifica-
tions from previously published standard differential
centrifugation methods (27). Media from the C2C12
myotube cultures (days 34 of differentiation) was thawed
and concentrated in a Centricon Plus-70 filter (100 K
NMWL, Millipore), spun at 12,000 g for 20 minutes,
the supernatant removed and spun at 120,000 g for 70
minutes (Beckman Ti SW-41 rotor). The resulting pellet
was re-suspended in Dulbecco’s PBS with 20 mM Hepes.
Protein concentration was determined using a micro-
BCA kit (Pierce Biotechnology, Rockford, IL). Small
samples of extracellular vesicles were labelled with
PKH26 (Sigma Aldrich, St. Louis, MO) according to the
manufacturers specifications in order to visualize extra-
cellular vesicle uptake by the NSC-34 cultured cells.
Briefly, purified extracellular vesicles were diluted in 1 ml
of diluent C, and then added to 1 ml of the prepared dye
(410
6 M) and incubated at room temperature (RT)
for 3 and ½ minutes. To stop the reaction, an excess of
protein was added in the form of 2 ml of 1% cytochrome
C (Sigma Aldrich) and incubated for 1 more minute. This
was then diluted by adding 11 ml of PBS and the labelled
vesicles were concentrated in an Amicon 15 spin column
(100 K NMWL, Millipore) spun at 3,000 g for 30 minutes
at 48C. The small size of cytochrome C (12.4 Kd) allows
it to freely pass through the 100 K NMWL filter. The
washing procedure with PBS was repeated 3 times. After
the final wash, the exosomes were collected from the spin
column and stored at 48C until used. As a control, a dye-
only sample was treated identically.
The presence of CD63 and calnexin was determined
by Western blot analysis. CD63 is a common marker for
extracellular vesicles and calnexin is a sensitive indicator
of the purity of the raw conditioned media since it is
a marker for endoplasmic reticulum, which could be
present in the conditioned media due to C2C12 cell lysis
and might co-precipitate with the extracellular vesicles.
Roger D. Madison et al.
2
(page number not for citation purpose)
Citation: Journal of Extracellular Vesicles 2014, 3: 22865 - http://dx.doi.org/10.3402/jev.v3.22865Equal amounts of protein from C2C12 cell lysates or
extracellular vesicles purified from C2C12 conditioned
media were loaded onto Nu Page 412% Bis-Tris gels
(Life Technologies, California) and processed according
to standard procedures; the primary and secondary
antibodies for CD63 were from System Biosciences, CA
(kit# EXOAB-CD63A-1), the primary calnexin antibody
was from Abcam, MA (ab22595) with a secondary anti-
body HRP-conjugate from Jackson Laboratories (111-
035-003), and the primary actin antibody was from
Santa Cruz (sc-47778) with a secondary antibody HRP-
conjugate from Jackson Laboratories (111-035-003).
The extracellular vesicle size range was estimated by the
Nanosight instrument (Nanosight Limited, England).
Figure 2 illustrates typical nanosight data from 247
tracks that were analyzed as follows: automatic blur,
track length and size; detection threshold 8 multi; temp-
erature 248C; viscosity 0.91 cP; frames per second 13.54;
EMCCD camera gain set at 464; measurement time of 90
seconds with one 10-second video recorded; drift velocity
548 nm/s; and a camera shutter of 47 ms.
NSC-34
The NSC-34 motor neuron cell line (CELLutions Bio-
systems Inc., Ontario) was maintained in growth media
consisting of DMEM supplemented with 10% FBS,
4m ML-glutamine (Gibco), 2.5 mg/ml amphotericin B
(Fisher Scientific) and 100 U/ml penicillin/100 mg/ml
streptomycin (Gibco). Cells were sub-cultured every 34
days prior to reaching confluence. To differentiate, the
cells cultures were switched to differentiation media
consisting of Neurobasal (Gibco), 4 mM L-glutamine
(Gibco), 2.5 mg/ml amphotericin B (Fisher Scientific), 100
U/ml penicillin/100 mg/ml streptomycin (Gibco).
NSC-34 neurite growth assay. NSC-34 cells were seeded
in duplicate onto collagen I coated 8 chamber slides
(BD Biocoat, Bedford, MA) at a density of 5.17510
3
cell/well in 300 ml in differentiation medium alone
(controls) or differentiation medium containing C2C12
myotube extracellular vesicles (200, 100, or 50 ng/ml).
These concentrations of vesicles are comparable to a ratio
of donor cells to recipient cells of 200:1, 100:1, or 50:1.
The concentration of extracellular vesicles (as judged by
total protein) was chosen so that on a per-cell basis the
extracellular vesicles concentration would be equivalent
between the axon outgrowth assay and the viability assay
(see below). Slides were incubated for 4 days after which
they were fixed with 2% paraformaldehyde (w/v) for 30
minutes at RT and washed 35 minutes in PBS. Care
was taken during fixing and washing process so as to
minimize the number of cells that were dislodged from
the substrate. Immunocytochemistry was carried out as
follows; nonspecific binding sites were blocked with 10%
normal goat serum (Vector Laboratories, Burlingame, CA),
6% bovine serum albumin (Sigma Aldrich), 0.1% Triton
X-100 (Promega) for 1 hour at RT. Cells were then
incubated in primary antibody 1:500 Neuronal Class III
b-tubulin (Clone TUJ1 1-15-79, Covance, Dedham, MA)
overnight at 48C, washed for 35 minutes in PBS and
incubated in secondary antibody 1:1000 Alexa Fluor 555
goat anti-rabbit IgG (HL) (Invitrogen, Eugene, OR)
for 1 hour at RT. Slides were mounted with Prolong, with
DAPI (Invitrogen, Eugene, OR).
Semi-automated analysis of neurite length and com-
plexity was carried out by an unbiased observer using the
NeuriteQuant program (28), which is freely available and
functions as a plug-in for the ImageJ analysis program.
Images were obtained using a 10 lens in a fluorescently
equipped microscope, and consisted of every-other visual
field of the 8-well chamber. Two separate images were
taken at each location, 1 for b-tubulin to visualize neurite
growth and 1 for DAPI to visualize the cell nucleus. The
images were processed in Photoshop CS6 for analysis
using layer stacking of the DAPI and b-tubulin images
followed by adjusting the overall levels to minimize
background noise to signal. The NeuriteQuant para-
meters were then optimized to properly select neurite and
cell body morphology followed by batch quantification
using identical neurite analysis parameters for all cells
in the study. NeuriteQuant analysis was carried out
for  6,000 motor neurons representing 8 independent
repetitions of each extracellular vesicle concentration,
using 2 independently prepared batches of extracellular
vesicles from conditioned media from 2 independent
C2C12 myotube cultures.
NSC-34 cell viability assay. NSC34 cells were seeded in
quadruplicates at a densityof 1.210
3cells/well in 100 mli n
opaque tissue culture treated 96-well plates (CELLSTAR,
Greiner Bio-One, Monroe, NC) in either differentiation
medium alone, or differentiation medium containing vari-
ous amounts of extracellular vesicles (46, 23, or 11.5 ng/
ml) isolated from media of the 34 day differentiated
C2C12 myotube cultures as described above. Plates
were incubated at 378C for 4 days and CellTiter-Glo
Luminescent Cell Viability Assay (Promega) was per-
formed according to the manufacturer’s protocol.
Statistics. Multiple group comparisons were first carried
out with a General Linear Model (ANOVA, with F- and
p-values as indicated) and post-hoc comparisons between
groups were carried out with t-tests (Fisher least sig-
nificant difference, p-values as indicated).
Results
Time course of C2C12 myosin expression
The differentiation of the myoblast C2C12 cell line into
differentiated contractile myotubes (as indicated by
myosin expression) is shown in Fig. 1. Myosin begins to
be detected by immunohistochemistry and Western blot
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in extracellular vesicles from differentiated C2C12 myo-
tubes as opposed to non-differentiated myoblasts because
we wanted to relate our results to adult motor neuron
regeneration rather than developmental aspects that
might shape such projections prior to the completion of
muscle development.
Characterization of C2C12 myotube extracellular
vesicles
The range of extracellular vesicles sizes as estimated by
the Nanosight instrument was primarily 100 nm and less
with a peak around 54 nm. CD63 is often used as a
characteristic protein marker for extracellular vesicles
whereas calnexin is a marker for endoplasmic reticulum
that would be expected to be present in C2C12 cells but
significantly reduced in the extracellular vesicle fraction.
Figure 2 illustrates that CD63 was present in the extra-
cellular vesicle fraction while calnexin was significantly
reduced compared to the cell lysate, thus demonstrating
the ability of the purification protocol to effectively enrich
extracellular vesicles from other cellular constituents.
Extracellular vesicle uptake in vitro and NeuriteQuant
analysis of motor neuron process outgrowth
Fluorescently labelled extracellular vesicles were used to
demonstrate uptake by the motor neuron cells in culture.
Motor neurons displayed extensive uptake of the PKH
dye-labelled vesicles (Fig. 3) while cultures that received
an equal volume of the dye-only retentate from the label-
ling reaction did not display any PKH fluorescence.
Motor neuron process outgrowth was quantified using
the NeuriteQuant analysis program. A typical raw image
and the corresponding processed image are shown in
Fig. 4 for both an extracellular vesicle and control treated
sample. The NeuriteQuant program automatically col-
lects data concerning number and size of cell bodies, the
number and length of neurite processes, and the com-
plexity of the processes in terms of the number of branch
points per process. There was a dramatic effect of
extracellular vesicles from the muscle cells on the average
neurite length per neuron, the neurite complexity index
(number of branches per neurite), average neuronal cell
size, and the total number of cells surviving after 4 days
in culture (see Fig. 5). Some of these outcome measures
Fig. 1. Time course of myosin expression in serum-free AIM-V media (Invitrogen). After propagating cells in DMEM with foetal
bovine serum the cells are switched to Aim-V. Panel (A) shows staining for myosin in the early differentiation phase, showing the
beginning of myotube formation. Panel (B) shows the expression of myosin begins by day 3 and is still present by day 7.
Fig. 2. Characterization of C2C12 extracellular vesicles. (A) The Nanosight instrument and nanoparticle tracking analysis revealed
vesicles primarily 100 nm and less with a peak around 54 nm. (B) Western blot showing the presence of the tetraspanin CD-63 which is a
standard marker for extracellular vesicles (24 mg of total protein loaded per lane). (C) Western blot showing signiﬁcant reduction of the
endoplasmic reticulum marker calnexin in the extracellular vesicle fraction compared to the cell lysate which validates the enrichment
procedure that was used to isolate the extracellular vesicles (12 mg of total protein loaded per lane). See Supplementary ﬁle for
uncropped images of the Western blots.
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5D) and other outcome measures showed significant
effects for all doses tested (5A and 5B). In these initial
experiments our primary purpose was to ‘‘bookend’’ the
effects on outgrowth of NSC-34 cells rather than carrying
out exhaustive dose-response curves, although we suspect
it is certainly quite likely that additional fractionated
doses would demonstrate dose-response effects on all the
outcome measures. Pilot experiments demonstrated that
changing media in the culture dishes resulted in notice-
able loss of the fine neuritic processes, and that culture
conditions began to deteriorate at longer survival times.
Therefore, we chose a 4-day time point to analyze neurite
outgrowth because at that time neurites were clearly
present as judged by phase contrast microscopy.
NSC-34 cell viability assay
In order to more systematically investigate the cell
survival effect of extracellular vesicle addition, we carried
out the CellTiter-Glo Luminescent Cell Viability Assay
(Promega, Madison, WI) in a 96-well format. This assay
uses a luciferase reaction to measure the amount of ATP
from viable cells. The amount of ATP in cells correlates
with cell viability, because within minutes after mem-
brane disruption cells lose the ability to synthesize new
ATP and the endogenous ATPases destroy any remaining
ATP. We first examined the robustness of this assay
to generate a standard curve that accurately reflected
the number of motor neurons plated immediately after
determining their number with a hemocytometer. We
were able to obtain linear results (r
2 of 0.99) over 4 orders
of magnitude, within the equivalent density range we
used for the NeuriteQuant analysis (1.210
3/0.7 cm
2),
and with a reliable detection limit of approximately 15
cells. This assay corroborated the findings from the
NeuriteQuant data in terms of there being a dramatic
effect on cell survival that was dose dependent (see Fig. 6).
The results are from 3 independent 96-well plates for each
extracellular vesicle concentration, with each plate being
an independent batch of NSC-34 cells, and also repre-
senting 2 independently prepared batches of extracellular
vesicles from conditioned media from 2 independent
C2C12 myotube cultures.
Discussion
Functional recovery following peripheral nerve repair
is largely dependent upon regenerating axons correctly
re-innervating their original end organs, e.g. skin and
muscle. Our laboratory has a long-standing interest in
the field of peripheral nerve repair and the underlying
Fig. 3. The motor neuron cell line NSC-34 was exposed to ﬂuorescently labelled vesicles for 3 hours, then ﬁxed and stained for
neuroﬁlament to label neurite processes. There was extensive uptake of the labelled vesicles by the neurite processes with some
indication of accumulation around perinuclear regions. Size bar 50 microns.
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motor neurons back to muscle (2934). We have cham-
pioned the hypothesis that muscle, as an end organ,
elaborates signals that regenerating motor neurons re-
spond to at a more proximal repair site (see especially
(32)). The current in vitro studies were undertaken to
examine the possibility that extracellular vesicles from
a muscle cell line could influence the outgrowth and
survival of a motor neuron cell line.
The C2C12 skeletal muscle cell line has been exten-
sively described previously (3538). This myoblast-like
cell line can be rapidly differentiated into contractile
myotubes, which produce characteristic muscle proteins,
e.g. myosin. Recent reports have also suggested that this
cell line, like most cell lines, secretes extracellular vesicles
into the culture media (24). The NSC-34 motor neuron
cell line was developed as a fusion between N18TG2
neuroblastoma cells and neuron-enriched embryonic day
1214 spinal cord cells. This cell line expresses many of
the morphological and physiological properties of motor
neurons including, extension of processes, formation of
contacts with cultured myotubes, synthesis and storage
of acetylcholine, support of action potentials, induction
of myotube twitching, and expression of neurofilament
proteins (39).
The results of the current experiments show that when
extracellular vesicles were harvested from differentiated
C2C12 cells and applied to the NSC-34 motor neuron cell
line there were significant increases in both cell survival
as well as neurite outgrowth. Several of these effects were
clearly dose dependent, such as effects on motor neuron
cell body size and survival (Figs. 5C, 5D, and 6). In terms
of the cell survival effects, the 96-well CellTiter-glo assay
showed a significant enhancement of cell survival at all
3 of the extracellular vesicle concentrations whereas the
NeuriteQuant analysis only showed an effect for the
2 highest concentrations. We consider the Cell Titer assay
to be a more sensitive measure of survival because once
the cells are plated into the wells nothing is added or
removed before adding the assay reagents and reading the
Fig. 4. NeuriteQuant analyses of motor neuron process outgrowth. (A and B) Raw images from control (no vesicles) and vesicle-treated
cultures. (C and D) Processed image after running NeuriteQuant program. (E and F) Higher power image of inset boxes from C&D to
show various aspects of the quantiﬁed data. Motor neuron cell bodies are shown in yellow, neurite processes are shown in blue, with
their attachment points to the cell bodies indicated by small white circles, and their end points indicated by small red circles. Size bar in
A100 microns and in E30 microns.
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possibility of losing some cells during the several fixing,
washing, and staining steps necessary to carry out the
analyses, and thus it may be more difficult to discern
small differences. Interestingly, the stimulatory effects on
average neurite length and complexity were observed at
all of the extracellular vesicle doses used in these studies
(Fig. 5A and 5B). Further work will be necessary to deter-
mine if this might suggest different underlying mechan-
isms for these various outcome measures, or if the ability
of motor neurons in these conditions to grow a longer
and more complex neurite is simply more sensitive to the
application of muscle cell extracellular vesicles.
It has recently been suggested that extracellular vesi-
cles secreted by stem cells, rather than the stem cells
themselves are the mediators of some of the well-known
ability of stem cells to reduce tissue injury and enhance
tissue repair (40,41). This is of interest in terms of recent
work showing an enhancement of sciatic nerve regenera-
tion in the rat due to transplantation of mesenchymal
stem cells into the nerve lesion (42), and suggests the
possibility that just as has been found in other research
fields, extracellular vesicles themselves may play a role in
nerve regeneration. An additional aspect of extracellular
vesicles that makes them ideal long distance messengers
is that the internal molecular contents of extracellular
vesicles are protected from degradation by trypsin and
RNAse as long they remain intact (43,44). All of these
findings suggest that using extracellular vesicles from stem
cells instead of the cells themselves could be beneficial
because of reduced concerns for safety and inherent
limitations due to transplanting viable replicating cells.
Fig. 5. NeuriteQuant analysis (mean9SEM). Motor neuron cells were cultured for 4 days in the presence or absence of varying
concentrations of vesicles puriﬁed from conditioned media of muscle cells as described in the text. Semi-automated analysis of average
neurite length per neuron (A), and the complexity of the neurites as judged by the number of branches per neurite (B) indicates a
signiﬁcant increase in length and complexity for all vesicle-treated groups compared to control (F0.04, t-tests B0.05). (C) There was
a dose-response effect on cell body size due to vesicle treatment compared to control that showed a trend at 100 ng/ml( p 0.06) and
reached statistical signiﬁcance with the 200 ng/ml vesicle group (F0.02, t-tests 0.06 and B 0.01, respectively). (D) The total cell
count also displayed a dose-response effect that reached signiﬁcance with the 200 ng/ml vesicle group (F 0.05, t-test0.03). The
graphed results for each outcome measure are from conditioned media from 2 independent C2C12 myotube cultures (i.e. 2 biological
replicates), with 2 independently prepared batches of extracellular vesicles from each media preparation (i.e. biological replicates), with
8 repetitions of each concentration (i.e. technical replicates). In total, the data represent NeuriteQuant analysis for  6,000 motor
neurons. The ‘‘N’’ used for statistics was 4, obtained by the number of biological replicates of vesicle preparations.
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nerve regeneration is just beginning to be investigated.
Our current work in vitro shows that extracellular vesicles
from muscle (the target end organ of motor neurons)
have significant effects on motor neuron survival and
neurite outgrowth. There will certainly be significant
challenges in terms of translating such findings into in
vivo applications to increase motor neuron regeneration
accuracy. However, we are encouraged by recent elegant
work from the laboratory of Felipe Court (25), which has
shown that extracellular vesicles harvested from cultured
Schwann cells enhance in vivo axonal regeneration in the
rat sciatic nerve, and the recovery of function as judged
by the pinch test. The results of that work clearly demon-
strated the possibility of in vitro harvested extracellular
vesicles to affect nerve regeneration in vivo. There is also
a precedent in the sense that extracellular vesicles from
various cell types are already in clinical trials in the
tumour biology field (45), and because extracellular
vesicles are immunologically tolerated, display targeting
ligands on their surface, can cross biological barriers
and can be delivered in vivo to selected cell populations
(27,4648), it is certainly worthwhile to pursue such work
in relation to nerve regeneration.
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